CYCS and glioblastoma: Levels of cytochrome c in human TMZ-sensitive U87 MG and TMZ-resistant U87 MG-R glioblastoma cells were enhanced following exposure to 50 μM enzalutamide for 72 h (Figure 5A, top panels).